Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery
Abstract Objective To update our report on the outcome of patients who underwent extended pelvic resection (EPR) for recurrent or persistent uterine and cervical malignancies. Methods We reviewed the records of all patients who underwent EPR between 6/2000 and 07/2011. EPR was defined as an en-bloc...
Gespeichert in:
Veröffentlicht in: | Gynecologic oncology 2012-05, Vol.125 (2), p.404-408 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 408 |
---|---|
container_issue | 2 |
container_start_page | 404 |
container_title | Gynecologic oncology |
container_volume | 125 |
creator | Andikyan, V Khoury-Collado, F Sonoda, Y Gerst, S.R Alektiar, K.M Sandhu, J.S Bochner, B.H Barakat, R.R Boland, P.J Chi, D.S |
description | Abstract Objective To update our report on the outcome of patients who underwent extended pelvic resection (EPR) for recurrent or persistent uterine and cervical malignancies. Methods We reviewed the records of all patients who underwent EPR between 6/2000 and 07/2011. EPR was defined as an en-bloc resection of a pelvic tumor with sidewall muscle, bone, major nerve, and/or major vascular structure. Complications up to 180 days post surgery were analyzed. Survivals were estimated using the Kaplan–Meier method. Results We identified 22 patients. Median age at the time of EPR was 58 years (range, 36–74). Median tumor diameter was 5.4 cm (range, 1.5–11.2). Primary tumor sites included: uterus, 13; cervix, 7; synchronous uterus/cervix, 1; and synchronous uterus/ovary, 1. The EPR structures were: muscle, 13; nerve, 10; bone, 8; vessel, 5. Complete gross resection with microscopically negative margins (R0 resection) was achieved in 17 patients (77%). There were no perioperative mortalities. Major postoperative complications occurred in 14 patients (64%). The two most common morbidities were pelvic abscesses and peripheral neuropathies. Median follow-up time was 28 months (range, 6–99). The 5-year overall survival (OS) for the entire cohort was 34% (95% CI, 13–57). For the 17 patients who had an R0 resection, the 5-year OS was 48% (95% CI, 19–73). In patients with positive pathologic margins (n = 5), the 5-year OS was 0%. Conclusion EPR was associated with prolonged survival when an R0 resection was achieved. The high rate of postoperative complications remains a hallmark of these procedures and properly selected patients should be extensively counseled preoperatively. |
doi_str_mv | 10.1016/j.ygyno.2012.01.031 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_993102650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090825812000637</els_id><sourcerecordid>993102650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-2ec78741110dc4db5a487bc7f808cc0049805b089fa9fd0a08a7e09ce3a2099c3</originalsourceid><addsrcrecordid>eNqFkUFv1DAUhC0EokvhFyAh3zhleXaSjY0EUlWVFqkSB-BsOfbL4iVrB9upmgP_HYctHLhwskaamSd_Q8hLBlsGbPfmsF32iw9bDoxvgW2hZo_IhoFsq51o5WOyAZBQCd6KM_IspQMA1MX7lJxxzkUrmmZDfl7dZ_QWLZ1wvHOGRkxosgs-0SHEIs0cI_pMi5gwJpfyquaM0Xmk2ltqMJakHulRj27vtTcO01t64ek8WZ2RBk_DXBoGmr8h7cM9TXPcY1yekyeDHhO-eHjPydcPV18ub6rbT9cfLy9uK9OwOlccTSe6hjEG1jS2b3Ujut50gwBhDEAjBbQ9CDloOVjQIHSHIA3WmoOUpj4nr0-9Uww_ZkxZHV0yOI7aY5iTkrJmwHctFGd9cpoYUoo4qCm6o46LYqBW7OqgfmNXK3YFTBXsJfXqoX_uj2j_Zv5wLoZ3JwOWX945jCoVSN6gdYVwVja4_xx4_0_ejM6v0L_jgukQ5ugLQMVUKhn1eV1-HZ7xMvqu7upf8Zyrzg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>993102650</pqid></control><display><type>article</type><title>Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Andikyan, V ; Khoury-Collado, F ; Sonoda, Y ; Gerst, S.R ; Alektiar, K.M ; Sandhu, J.S ; Bochner, B.H ; Barakat, R.R ; Boland, P.J ; Chi, D.S</creator><creatorcontrib>Andikyan, V ; Khoury-Collado, F ; Sonoda, Y ; Gerst, S.R ; Alektiar, K.M ; Sandhu, J.S ; Bochner, B.H ; Barakat, R.R ; Boland, P.J ; Chi, D.S</creatorcontrib><description>Abstract Objective To update our report on the outcome of patients who underwent extended pelvic resection (EPR) for recurrent or persistent uterine and cervical malignancies. Methods We reviewed the records of all patients who underwent EPR between 6/2000 and 07/2011. EPR was defined as an en-bloc resection of a pelvic tumor with sidewall muscle, bone, major nerve, and/or major vascular structure. Complications up to 180 days post surgery were analyzed. Survivals were estimated using the Kaplan–Meier method. Results We identified 22 patients. Median age at the time of EPR was 58 years (range, 36–74). Median tumor diameter was 5.4 cm (range, 1.5–11.2). Primary tumor sites included: uterus, 13; cervix, 7; synchronous uterus/cervix, 1; and synchronous uterus/ovary, 1. The EPR structures were: muscle, 13; nerve, 10; bone, 8; vessel, 5. Complete gross resection with microscopically negative margins (R0 resection) was achieved in 17 patients (77%). There were no perioperative mortalities. Major postoperative complications occurred in 14 patients (64%). The two most common morbidities were pelvic abscesses and peripheral neuropathies. Median follow-up time was 28 months (range, 6–99). The 5-year overall survival (OS) for the entire cohort was 34% (95% CI, 13–57). For the 17 patients who had an R0 resection, the 5-year OS was 48% (95% CI, 19–73). In patients with positive pathologic margins (n = 5), the 5-year OS was 0%. Conclusion EPR was associated with prolonged survival when an R0 resection was achieved. The high rate of postoperative complications remains a hallmark of these procedures and properly selected patients should be extensively counseled preoperatively.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1016/j.ygyno.2012.01.031</identifier><identifier>PMID: 22285844</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Complication ; Exenteration ; Extended pelvic resection ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Middle Aged ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - surgery ; Neoplasm Staging ; Obstetrics and Gynecology ; Outcome ; Pelvic Exenteration - adverse effects ; Pelvic Exenteration - methods ; Recurrence ; Survival Rate ; Treatment Outcome ; Uterine Cervical Neoplasms - pathology ; Uterine Cervical Neoplasms - surgery ; Uterine Neoplasms - pathology ; Uterine Neoplasms - surgery</subject><ispartof>Gynecologic oncology, 2012-05, Vol.125 (2), p.404-408</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-2ec78741110dc4db5a487bc7f808cc0049805b089fa9fd0a08a7e09ce3a2099c3</citedby><cites>FETCH-LOGICAL-c413t-2ec78741110dc4db5a487bc7f808cc0049805b089fa9fd0a08a7e09ce3a2099c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0090825812000637$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22285844$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Andikyan, V</creatorcontrib><creatorcontrib>Khoury-Collado, F</creatorcontrib><creatorcontrib>Sonoda, Y</creatorcontrib><creatorcontrib>Gerst, S.R</creatorcontrib><creatorcontrib>Alektiar, K.M</creatorcontrib><creatorcontrib>Sandhu, J.S</creatorcontrib><creatorcontrib>Bochner, B.H</creatorcontrib><creatorcontrib>Barakat, R.R</creatorcontrib><creatorcontrib>Boland, P.J</creatorcontrib><creatorcontrib>Chi, D.S</creatorcontrib><title>Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Abstract Objective To update our report on the outcome of patients who underwent extended pelvic resection (EPR) for recurrent or persistent uterine and cervical malignancies. Methods We reviewed the records of all patients who underwent EPR between 6/2000 and 07/2011. EPR was defined as an en-bloc resection of a pelvic tumor with sidewall muscle, bone, major nerve, and/or major vascular structure. Complications up to 180 days post surgery were analyzed. Survivals were estimated using the Kaplan–Meier method. Results We identified 22 patients. Median age at the time of EPR was 58 years (range, 36–74). Median tumor diameter was 5.4 cm (range, 1.5–11.2). Primary tumor sites included: uterus, 13; cervix, 7; synchronous uterus/cervix, 1; and synchronous uterus/ovary, 1. The EPR structures were: muscle, 13; nerve, 10; bone, 8; vessel, 5. Complete gross resection with microscopically negative margins (R0 resection) was achieved in 17 patients (77%). There were no perioperative mortalities. Major postoperative complications occurred in 14 patients (64%). The two most common morbidities were pelvic abscesses and peripheral neuropathies. Median follow-up time was 28 months (range, 6–99). The 5-year overall survival (OS) for the entire cohort was 34% (95% CI, 13–57). For the 17 patients who had an R0 resection, the 5-year OS was 48% (95% CI, 19–73). In patients with positive pathologic margins (n = 5), the 5-year OS was 0%. Conclusion EPR was associated with prolonged survival when an R0 resection was achieved. The high rate of postoperative complications remains a hallmark of these procedures and properly selected patients should be extensively counseled preoperatively.</description><subject>Adult</subject><subject>Aged</subject><subject>Complication</subject><subject>Exenteration</subject><subject>Extended pelvic resection</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Neoplasm Staging</subject><subject>Obstetrics and Gynecology</subject><subject>Outcome</subject><subject>Pelvic Exenteration - adverse effects</subject><subject>Pelvic Exenteration - methods</subject><subject>Recurrence</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Uterine Cervical Neoplasms - surgery</subject><subject>Uterine Neoplasms - pathology</subject><subject>Uterine Neoplasms - surgery</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFv1DAUhC0EokvhFyAh3zhleXaSjY0EUlWVFqkSB-BsOfbL4iVrB9upmgP_HYctHLhwskaamSd_Q8hLBlsGbPfmsF32iw9bDoxvgW2hZo_IhoFsq51o5WOyAZBQCd6KM_IspQMA1MX7lJxxzkUrmmZDfl7dZ_QWLZ1wvHOGRkxosgs-0SHEIs0cI_pMi5gwJpfyquaM0Xmk2ltqMJakHulRj27vtTcO01t64ek8WZ2RBk_DXBoGmr8h7cM9TXPcY1yekyeDHhO-eHjPydcPV18ub6rbT9cfLy9uK9OwOlccTSe6hjEG1jS2b3Ujut50gwBhDEAjBbQ9CDloOVjQIHSHIA3WmoOUpj4nr0-9Uww_ZkxZHV0yOI7aY5iTkrJmwHctFGd9cpoYUoo4qCm6o46LYqBW7OqgfmNXK3YFTBXsJfXqoX_uj2j_Zv5wLoZ3JwOWX945jCoVSN6gdYVwVja4_xx4_0_ejM6v0L_jgukQ5ugLQMVUKhn1eV1-HZ7xMvqu7upf8Zyrzg</recordid><startdate>20120501</startdate><enddate>20120501</enddate><creator>Andikyan, V</creator><creator>Khoury-Collado, F</creator><creator>Sonoda, Y</creator><creator>Gerst, S.R</creator><creator>Alektiar, K.M</creator><creator>Sandhu, J.S</creator><creator>Bochner, B.H</creator><creator>Barakat, R.R</creator><creator>Boland, P.J</creator><creator>Chi, D.S</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120501</creationdate><title>Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery</title><author>Andikyan, V ; Khoury-Collado, F ; Sonoda, Y ; Gerst, S.R ; Alektiar, K.M ; Sandhu, J.S ; Bochner, B.H ; Barakat, R.R ; Boland, P.J ; Chi, D.S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-2ec78741110dc4db5a487bc7f808cc0049805b089fa9fd0a08a7e09ce3a2099c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Complication</topic><topic>Exenteration</topic><topic>Extended pelvic resection</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Neoplasm Staging</topic><topic>Obstetrics and Gynecology</topic><topic>Outcome</topic><topic>Pelvic Exenteration - adverse effects</topic><topic>Pelvic Exenteration - methods</topic><topic>Recurrence</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Uterine Cervical Neoplasms - surgery</topic><topic>Uterine Neoplasms - pathology</topic><topic>Uterine Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andikyan, V</creatorcontrib><creatorcontrib>Khoury-Collado, F</creatorcontrib><creatorcontrib>Sonoda, Y</creatorcontrib><creatorcontrib>Gerst, S.R</creatorcontrib><creatorcontrib>Alektiar, K.M</creatorcontrib><creatorcontrib>Sandhu, J.S</creatorcontrib><creatorcontrib>Bochner, B.H</creatorcontrib><creatorcontrib>Barakat, R.R</creatorcontrib><creatorcontrib>Boland, P.J</creatorcontrib><creatorcontrib>Chi, D.S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andikyan, V</au><au>Khoury-Collado, F</au><au>Sonoda, Y</au><au>Gerst, S.R</au><au>Alektiar, K.M</au><au>Sandhu, J.S</au><au>Bochner, B.H</au><au>Barakat, R.R</au><au>Boland, P.J</au><au>Chi, D.S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>2012-05-01</date><risdate>2012</risdate><volume>125</volume><issue>2</issue><spage>404</spage><epage>408</epage><pages>404-408</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><abstract>Abstract Objective To update our report on the outcome of patients who underwent extended pelvic resection (EPR) for recurrent or persistent uterine and cervical malignancies. Methods We reviewed the records of all patients who underwent EPR between 6/2000 and 07/2011. EPR was defined as an en-bloc resection of a pelvic tumor with sidewall muscle, bone, major nerve, and/or major vascular structure. Complications up to 180 days post surgery were analyzed. Survivals were estimated using the Kaplan–Meier method. Results We identified 22 patients. Median age at the time of EPR was 58 years (range, 36–74). Median tumor diameter was 5.4 cm (range, 1.5–11.2). Primary tumor sites included: uterus, 13; cervix, 7; synchronous uterus/cervix, 1; and synchronous uterus/ovary, 1. The EPR structures were: muscle, 13; nerve, 10; bone, 8; vessel, 5. Complete gross resection with microscopically negative margins (R0 resection) was achieved in 17 patients (77%). There were no perioperative mortalities. Major postoperative complications occurred in 14 patients (64%). The two most common morbidities were pelvic abscesses and peripheral neuropathies. Median follow-up time was 28 months (range, 6–99). The 5-year overall survival (OS) for the entire cohort was 34% (95% CI, 13–57). For the 17 patients who had an R0 resection, the 5-year OS was 48% (95% CI, 19–73). In patients with positive pathologic margins (n = 5), the 5-year OS was 0%. Conclusion EPR was associated with prolonged survival when an R0 resection was achieved. The high rate of postoperative complications remains a hallmark of these procedures and properly selected patients should be extensively counseled preoperatively.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22285844</pmid><doi>10.1016/j.ygyno.2012.01.031</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-8258 |
ispartof | Gynecologic oncology, 2012-05, Vol.125 (2), p.404-408 |
issn | 0090-8258 1095-6859 |
language | eng |
recordid | cdi_proquest_miscellaneous_993102650 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Aged Complication Exenteration Extended pelvic resection Female Hematology, Oncology and Palliative Medicine Humans Middle Aged Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - surgery Neoplasm Staging Obstetrics and Gynecology Outcome Pelvic Exenteration - adverse effects Pelvic Exenteration - methods Recurrence Survival Rate Treatment Outcome Uterine Cervical Neoplasms - pathology Uterine Cervical Neoplasms - surgery Uterine Neoplasms - pathology Uterine Neoplasms - surgery |
title | Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T13%3A39%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extended%20pelvic%20resections%20for%20recurrent%20or%20persistent%20uterine%20and%20cervical%20malignancies:%20An%20update%20on%20out%20of%20the%20box%20surgery&rft.jtitle=Gynecologic%20oncology&rft.au=Andikyan,%20V&rft.date=2012-05-01&rft.volume=125&rft.issue=2&rft.spage=404&rft.epage=408&rft.pages=404-408&rft.issn=0090-8258&rft.eissn=1095-6859&rft_id=info:doi/10.1016/j.ygyno.2012.01.031&rft_dat=%3Cproquest_cross%3E993102650%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=993102650&rft_id=info:pmid/22285844&rft_els_id=S0090825812000637&rfr_iscdi=true |